Human Clinical Diagnostics Articles and Resources

Making qPCR molecular diagnostics accessible at point-of-care changed how we detect and treat major infectious diseases.

Pandemic containment in the United States has proved ineffective due to a lack of preparation and deployment of modern pathogen-detection technologies. Improved point-of-care molecular diagnostics will save lives when the next pandemic emerges.

Dr. Jack Regan, LexaGene’s CEO gives his perspective on fighting COVID-19 with better diagnostics and automated PCR testing.